Author headshot

Dana McClintock, MD

Dana McClintock, MD, is chief medical officer of Alladapt Immunotherapeutics.

Most recent by Dana McClintock, MD

SPONSORED CONTENT
January 26, 2022
6 min read
Save

Q&A: Study to assess single oral immunotherapy’s ability to treat multiple food allergens

Oral immunotherapy has shown promise in inducing remission of specific food allergies, with one FDA-approved option available for peanut allergy, but these patients often shoulder the burden of multiple food allergies.